Literature DB >> 20392852

RASCAL is a new human cytomegalovirus-encoded protein that localizes to the nuclear lamina and in cytoplasmic vesicles at late times postinfection.

Matthew S Miller1, Wendy E Furlong, Leesa Pennell, Marc Geadah, Laura Hertel.   

Abstract

The products of numerous open reading frames (ORFs) present in the genome of human cytomegalovirus (CMV) have not been characterized. Here, we describe the identification of a new CMV protein localizing to the nuclear envelope and in cytoplasmic vesicles at late times postinfection. Based on this distinctive localization pattern, we called this new protein nuclear rim-associated cytomegaloviral protein, or RASCAL. Two RASCAL isoforms exist, a short version of 97 amino acids encoded by the majority of CMV strains and a longer version of 176 amino acids encoded by the Towne, Toledo, HAN20, and HAN38 strains. Both isoforms colocalize with lamin B in deep intranuclear invaginations of the inner nuclear membrane (INM) and in novel cytoplasmic vesicular structures possibly derived from the nuclear envelope. INM infoldings have been previously described as sites of nucleocapsid egress, which is mediated by the localized disruption of the nuclear lamina, promoted by the activities of viral and cellular kinases recruited by the lamina-associated proteins UL50 and UL53. RASCAL accumulation at the nuclear membrane required the presence of UL50 but not of UL53. RASCAL and UL50 also appeared to specifically interact, suggesting that RASCAL is a new component of the nuclear egress complex (NEC) and possibly involved in mediating nucleocapsid egress from the nucleus. Finally, the presence of RASCAL within cytoplasmic vesicles raises the intriguing possibility that this protein might participate in additional steps of virion maturation occurring after capsid release from the nucleus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392852      PMCID: PMC2903262          DOI: 10.1128/JVI.02462-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  73 in total

1.  Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero.

Authors:  S D Elek; H Stern
Journal:  Lancet       Date:  1974-01-05       Impact factor: 79.321

2.  Candidate cytomegalovirus strain for human vaccination.

Authors:  S A Plotkin; T Furukawa; N Zygraich; C Huygelen
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

3.  The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome.

Authors:  Andrew J Davison; Aidan Dolan; Parvis Akter; Clare Addison; Derrick J Dargan; Donald J Alcendor; Duncan J McGeoch; Gary S Hayward
Journal:  J Gen Virol       Date:  2003-01       Impact factor: 3.891

4.  Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Authors:  Gabriele Hahn; Maria Grazia Revello; Marco Patrone; Elena Percivalle; Giulia Campanini; Antonella Sarasini; Markus Wagner; Andrea Gallina; Gabriele Milanesi; Ulrich Koszinowski; Fausto Baldanti; Giuseppe Gerna
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  Remodelling of the nuclear lamina during human cytomegalovirus infection: role of the viral proteins pUL50 and pUL53.

Authors:  Daria Camozzi; Sara Pignatelli; Cecilia Valvo; Giovanna Lattanzi; Cristina Capanni; Paola Dal Monte; Maria Paola Landini
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

6.  Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome.

Authors:  Susan M Varnum; Daniel N Streblow; Matthew E Monroe; Patricia Smith; Kenneth J Auberry; Ljiljana Pasa-Tolic; Dai Wang; David G Camp; Karin Rodland; Steven Wiley; William Britt; Thomas Shenk; Richard D Smith; Jay A Nelson
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 7.  Human cytomegalovirus genome.

Authors:  E Murphy; T Shenk
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 8.  Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease.

Authors:  W Britt
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 9.  Virus entry and innate immune activation.

Authors:  M K Isaacson; L K Juckem; T Compton
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

Review 10.  Cytomegalovirus cell tropism.

Authors:  C Sinzger; M Digel; G Jahn
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

View more
  10 in total

1.  Human Cytomegalovirus nuclear egress and secondary envelopment are negatively affected in the absence of cellular p53.

Authors:  Man I Kuan; John M O'Dowd; Kamila Chughtai; Ian Hayman; Celeste J Brown; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-05       Impact factor: 3.616

2.  Deletion of the human cytomegalovirus US17 gene increases the ratio of genomes per infectious unit and alters regulation of immune and endoplasmic reticulum stress response genes at early and late times after infection.

Authors:  Stephen J Gurczynski; Subhendu Das; Philip E Pellett
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  WDR5 Facilitates Human Cytomegalovirus Replication by Promoting Capsid Nuclear Egress.

Authors:  Bo Yang; Xi-Juan Liu; Yongxuan Yao; Xuan Jiang; Xian-Zhang Wang; Hong Yang; Jin-Yan Sun; Yun Miao; Wei Wang; Zhen-Li Huang; Yanyi Wang; Qiyi Tang; Simon Rayner; William J Britt; Michael A McVoy; Min-Hua Luo; Fei Zhao
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

4.  Human cytomegalovirus infection of langerhans-type dendritic cells does not require the presence of the gH/gL/UL128-131A complex and is blocked after nuclear deposition of viral genomes in immature cells.

Authors:  Elvin J Lauron; Dong Yu; Anthony R Fehr; Laura Hertel
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

Review 5.  Viral and host control of cytomegalovirus maturation.

Authors:  Ritesh Tandon; Edward S Mocarski
Journal:  Trends Microbiol       Date:  2012-05-23       Impact factor: 17.079

6.  The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress.

Authors:  Man I Kuan; John M O'Dowd; Elizabeth A Fortunato
Journal:  Virology       Date:  2016-08-04       Impact factor: 3.616

Review 7.  Herpesviruses and intermediate filaments: close encounters with the third type.

Authors:  Laura Hertel
Journal:  Viruses       Date:  2011-07-04       Impact factor: 5.048

Review 8.  Nuclear actin and lamins in viral infections.

Authors:  Jakub Cibulka; Martin Fraiberk; Jitka Forstova
Journal:  Viruses       Date:  2012-02-28       Impact factor: 5.048

9.  Orchestration of protein acetylation as a toggle for cellular defense and virus replication.

Authors:  L A Murray; X Sheng; I M Cristea
Journal:  Nat Commun       Date:  2018-11-23       Impact factor: 14.919

Review 10.  Nuclear Cytoskeleton in Virus Infection.

Authors:  Lenka Horníková; Kateřina Bruštíková; Sandra Huérfano; Jitka Forstová
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.